ArticleScientific reports2016

High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.

Julia K Polansky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.